News & Updates

A study from the US finds that compared with afternoon infusions, morning infusions of immune checkpoint inhibitors (ICI) confer a modest but clinically meaningful overall survival (OS) benefit to patients with non-small-cell lung cancer (NSCLC).

Icotrokinra—the first and only targeted oral peptide designed to selectively block the interleukin-23 receptor (IL-23R), which has been approved for the treatment of plaque psoriasis—shows multiple favourable signals for the treatment of ulcerative colitis (UC), according to updated data from the phase IIb ANTHEM-UC study.

Hyposmia and hypogeusia are not unique to children with acute SARS-CoV-2 infection in the omicron era, but long COVID can cause continuing taste and smell impairments that are not detected by validated questionnaires, according to a study.